Literature DB >> 12882861

Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study.

Graziella Bruno1, Annibale Biggeri, Franco Merletti, Giuseppe Bargero, Stefania Ferrero, Gianfranco Pagano, Paolo Cavallo Perin.   

Abstract

OBJECTIVE: Data on the incidence of end-stage renal disease (ESRD) and chronic renal failure from population-based studies in Caucasian type 2 diabetic patients are lacking. To provide such data, a population-based cohort of type 2 diabetic patients was identified in Casale Monferrato, Italy, and prospectively examined from 1991 to 2001. RESEARCH DESIGN AND METHODS: During the follow-up period, patients were regularly examined with centralized measurements of plasma creatinine and HbA(1c). Independent predictors of progression to renal events were identified with multivariate Cox proportional hazards modeling, with sex, age, and individual follow-up time as confounders.
RESULTS: We followed 1,408 of 1,540 (91.4%) patients (average follow-up time 6.7 years, range 0.011-11.1); 10 new cases of ESRD and 72 of chronic renal failure (plasma values of creatinine >or=2.0 mg/dl) were identified, giving incidence rates/1,000 person-years of 1.04 (95% CI 0.56-1.94) and 7.63 (6.06-9.61), respectively. Cumulative risks for chronic renal failure adjusted for competing mortality were 6.1 and 9.3% after 20 and 30 years from diagnosis of diabetes, respectively. Incidence rates and cumulative risks of chronic renal failure defined by plasma creatinine values >1.5 mg/dl increased to 13.1/1,000 person-years, 8.6 and 14.8%, respectively. In Cox regression analysis, predictors of progression (after adjustment for confounders) were hypertension (P = 0.078), diastolic blood pressure (P = 0.034), BMI (P = 0.03), and albumin excretion rate (AER) (P < 0.0001).
CONCLUSIONS: We provide evidence that the individual risk of ESRD and chronic renal failure is low. AER and diastolic blood pressure are independent predictors of progression. These findings underline the relevance of primary prevention to reduce the number of diabetic patients with ESRD.

Entities:  

Mesh:

Year:  2003        PMID: 12882861     DOI: 10.2337/diacare.26.8.2353

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Type 2 diabetes and hemoglobin A1c targets.

Authors:  G Michael Allan; David Ross; Jacques Romney
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

2.  Sulfonylurea treatment in type 2 diabetes.

Authors:  Kirstin Bester; Joey Ton; Christina Korownyk
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

3.  Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study.

Authors:  G Bruno; F Merletti; G Bargero; G Novelli; D Melis; A Soddu; M Perotto; G Pagano; P Cavallo-Perin
Journal:  Diabetologia       Date:  2007-03-02       Impact factor: 10.122

4.  Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

Authors:  G Bruno; F Merletti; A Biggeri; G Bargero; S Ferrero; G Pagano; P Cavallo-Perin
Journal:  Diabetologia       Date:  2005-02-05       Impact factor: 10.122

Review 5.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

6.  Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study.

Authors:  Chia-Jen Shih; Yueh-Lin Wu; Yuan-Hao Lo; Shu-Chen Kuo; Der-Cherng Tarng; Chih-Ching Lin; Shuo-Ming Ou; Yung-Tai Chen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

7.  Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul's Hospital, Addis Ababa, Ethiopia.

Authors:  Alemayehu Hussen Geletu; Alemayehu Shimeka Teferra; Malede Mequanent Sisay; Destaw Fetene Teshome
Journal:  BMC Res Notes       Date:  2018-07-31

8.  Derivation and Validation of a Prediction Model of End-Stage Renal Disease in Patients With Type 2 Diabetes Based on a Systematic Review and Meta-analysis.

Authors:  Qiuyue Ren; Dong Chen; Xinbang Liu; Ronglu Yang; Lisha Yuan; Min Ding; Ning Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

9.  The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis.

Authors:  Tadashi Toyama; Kengo Furuichi; Toshiharu Ninomiya; Miho Shimizu; Akinori Hara; Yasunori Iwata; Shuichi Kaneko; Takashi Wada
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 10.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.